Intraarterial chemotherapy as the first-line therapy in penile cancer

被引：0
|
作者：
P-H Chiang
C-H Chen
Y-C Shen
机构：
[1] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Department of Urology
[2] Graduate Institute of Medicine,undefined
[3] College of Medicine,undefined
[4] Kaohsiung Medical University,undefined
来源：
British Journal of Cancer | 2014年 / 111卷
关键词：
chemotherapy; intraarterial; neoadjuvant; penectomy; penile cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1089 / 1094
页数：5
相关论文
共 50 条
  • [31] Cost-Effectiveness of Atezolizumab Plus Chemotherapy as First-Line Therapy for Metastatic Urothelial Cancer
    Shuxia Qin
    Lidan Yi
    Sini Li
    Chongqing Tan
    Xiaohui Zeng
    Liting Wang
    Ye Peng
    Xiaomin Wan
    Advances in Therapy, 2021, 38 : 3399 - 3408
  • [32] Cost-Effectiveness of Atezolizumab Plus Chemotherapy as First-Line Therapy for Metastatic Urothelial Cancer
    Qin, Shuxia
    Yi, Lidan
    Li, Sini
    Tan, Chongqing
    Zeng, Xiaohui
    Wang, Liting
    Peng, Ye
    Wan, Xiaomin
    ADVANCES IN THERAPY, 2021, 38 (06) : 3399 - 3408
  • [33] Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer
    Vergote, Ignace
    Perez-Fidalgo, Jose Alejandro
    Hamilton, Erika Paige
    Valabrega, Giorgio
    Van Gorp, Toon
    Sehouli, Jalid
    Cibula, David
    Levy, Tally
    Welch, Stephen
    Richardson, Debra L.
    Guerra, Eva M.
    Scambia, Giovanni
    Henry, Stephanie
    Wimberger, Pauline
    Miller, David S.
    Klat, Jaroslav
    Martinez-Garcia, Jeronimo
    Raspagliesi, Francesco
    Pothuri, Bhavana
    Romero, Ignacio
    Bergamini, Alice
    Slomovitz, Brian
    Schochter, Fabienne
    Hogdall, Estrid
    Farinas-Madrid, Lorena
    Monk, Bradley J.
    Michel, Dayana
    Kauffman, Michael G.
    Shacham, Sharon
    Mirza, Mansoor Raza
    Makker, Vicky
    Vergote, Ignace
    Van Gorp, Toon
    Cadron, Isabelle
    Barbeaux, Annelore
    Cornez, Nathalie
    Henry, Stephanie
    Kerger, Joseph
    Debaere, Debbie
    Denys, Hannelore
    Mirza, Mansoor Raza
    Oza, Amit
    Gilbert, Lucy
    Welch, Stephen
    Kolinsky, Michael
    Zhou, Qi
    Wang, Jing
    Yang, Yingjie
    Tu, Kaijia
    Wang, Li
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (35) : 5400 - +
  • [34] Definition of an optimal first-line chemotherapy in metastatic breast cancer
    Heinemann, V
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 81 : S43 - S48
  • [35] Taxanes in the first-line chemotherapy of metastatic breast cancer: Review
    Friedrich, M
    Diesing, D
    Villena-Heinsen, C
    Felberbaum, R
    Kolberg, HC
    Diedrich, K
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2004, 25 (01) : 66 - 70
  • [36] Definition of An Optimal First-line Chemotherapy in Metastatic Breast Cancer
    Volker Heinemann
    Breast Cancer Research and Treatment, 2003, 81 (Suppl 1) : 43 - 48
  • [37] Vinorelbine and paclitaxel as first-line chemotherapy in metastatic breast cancer
    Acuña, LR
    Langhi, M
    Pérez, J
    Acuña, JR
    Machiavelli, M
    Lacava, J
    Vallejo, C
    Romero, A
    Fasce, H
    Ortiz, E
    Grasso, S
    Amato, S
    Rodríguez, R
    Barbieri, M
    Leone, B
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 74 - 81
  • [38] Testicular cancer: RPLND an effective first-line alternative to chemotherapy
    Payton S.
    Nature Reviews Urology, 2009, 6 (6) : 295 - 295
  • [39] Vinorelbine and docetaxel as first-line chemotherapy in metastatic breast cancer
    M. Vassilomanolakis
    G. Koumakis
    S. Drufakou
    G. Aperis
    M. Demiri
    V. Barbounis
    J. Missitzis
    A. Efremidis
    Cancer Chemotherapy and Pharmacology, 2003, 51 : 179 - 183
  • [40] Ifosfamide and vinorelbine as first-line chemotherapy for metastatic breast cancer
    Leone, BA
    Vallejo, CT
    Romero, AO
    Perez, JE
    Cuevas, MA
    Lacava, JA
    Sabatini, CL
    Dominguez, ME
    Rodriguez, R
    Barbieri, MR
    Ortiz, EH
    Salvadori, MA
    Acuna, LAR
    Acuna, JMR
    Langhi, MJ
    Amato, S
    Machiavelli, MR
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (11) : 2993 - 2999
12345